Business success from world-changing science.
Molecular Biology, Cell Biology, Synthetic Biology, Cell Therapy, Gene Therapy, Commercial Strategy, Technical Strategy.
How long have you worked at Cambridge Consultants?
I joined Cambridge Consultants in June 2016, so coming up to four years now.
What are your individual responsibilities?
I lead on business development for the Bioinnovation team at Cambridge Consultants, which means I work across the whole company to identify clients who could benefit from our capabilities in working at the intersection of biology, engineering and advanced computation to create market-leading products and services. In practice this means talking to companies across the world to help them identify the obstacles they are facing getting to market and increasing revenue, and working out ways we can help.
What are the best parts of your job?
I really enjoy the sheer variety of the different clients and challenges they face, and the incredible range of markets and applications they are targeting. We work with clients in lots of different sectors – advanced therapies, next-gen agritech, bioplastics and bioinformatics to name a few – and I really like the challenge of having to be up to speed on the latest developments in different fields.
Tell us about some of your achievements.
I’ve worked in technology transfer in academic and clinical settings for a long time, and I’m very proud of some of the spinout companies I helped start. There’s something really rewarding about seeing a passionate inventor or founder get their first seed money that really allows them to start pursuing their dream and turn their idea into reality. More recently at Cambridge Consultants I’ve been delighted to work with a great team in Bioinnovation to build a significant sustainable business, helping clients that range from startups to some of the world’s biggest companies adapt to the future of product development - i.e. a world of products based on biology.
What excites you about bioinnovation?
I think what excites me most is that bioinnovation will affect so many different industries – from the obvious ones like healthcare and agriculture to the more surprising like data storage and plastics. A company I know in California, Zymergen, sums up their offering as ‘new stuff, and new ways to make new stuff’ - who wouldn’t be excited by that?